Cited by 5,699Cardiovascular Function and Risk FactorsBlood Pressure and Hypertension StudiesCardiovascular Effects of Exercise

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

Open access

Levy, Daniel, Garrison, Robert J., Savage, Daniel D., Kannel, William B., Castelli, William P.·1990·New England Journal of Medicine

DOI 10.1056/nejm199005313222203

Open this paper in CoChat — free account Open PDF

Abstract

A pattern of left ventricular hypertrophy evident on the electrocardiogram is a harbinger of morbidity and mortality from cardiovascular disease. Echocardiography permits the noninvasive determination of left ventricular mass and the examination of its role as a precursor of morbidity and mortality. We examined the relation of left ventricular mass to the incidence of cardiovascular disease, mortality from cardiovascular disease, and mortality from all causes in 3220 subjects enrolled in the Framingham Heart Study who were 40 years of age or older and free of clinically apparent cardiovascular disease, in whom left ventricular mass was determined echocardiographically. During a four-year follow-up period, there were 208 incident cardiovascular events, 37 deaths from cardiovascular disease, and 124 deaths from all causes. Left ventricular mass, determined echocardiographically, was associated with all outcome events. This relation persisted after we adjusted for age, diastolic blood pressure, pulse pressure, treatment for hypertension, cigarette smoking, diabetes, obesity, the ratio of total cholesterol to high-density lipoprotein cholesterol, and electrocardiographic evidence of left ventricular hypertrophy. In men, the risk factor-adjusted relative risk of cardiovascular disease was 1.49 for each increment of 50 g per meter in left ventricular mass corrected for the subject's height (95 percent confidence interval, 1.20 to 1.85); in women, it was 1.57 (95 percent confidence interval, 1.20 to 2.04). Left ventricular mass (corrected for height) was also associated with the incidence of death from cardiovascular disease (relative risk, 1.73 [95 percent confidence interval, 1.19 to 2.52] in men and 2.12 [95 percent confidence interval, 1.28 to 3.49] in women). Left ventricular mass (corrected for height) was associated with death from all causes (relative risk, 1.49 [95 percent confidence interval, 1.14 to 1.94] in men and 2.01 [95 percent confidence interval, 1.44 to 2.81] in women). We conclude that the estimation of left ventricular mass by echocardiography offers prognostic information beyond that provided by the evaluation of traditional cardiovascular risk factors. An increase in left ventricular mass predicts a higher incidence of clinical events, including death, attributable to cardiovascular disease.

Integrity signals

Registry

Crossref · 10.1056/nejm199005313222203

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,226
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
Devereux, R. B., & Reichek, N. (1977) · Circulation · doi:10.1161/01.cir.55.4.613 · Cited by 4,499
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
Value of Echocardiographic Measurement of Left Ventricular Mass in Predicting Cardiovascular Morbid Events in Hypertensive Men
Casale, P. N., Devereux, R. B., Milner, M. R., Zullo, G., Harshfield, G. A., Pickering, T. G., & LARAGH, J. H. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-2-173 · Cited by 1,079
Echocardiographically Detected Left Ventricular Hypertrophy: Prevalence and Risk Factors
Levy, D. A., Anderson, K. M., SAVAGE, D. D., Kannel, W. B., Christiansen, J. C., & Castelli, W. P. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-1-7 · Cited by 819
Echocardiographic criteria for left ventricular hypertrophy: The Framingham heart study
Levy, D. A., Savage, D. D., Garrison, R. J., Anderson, K. M., Kannel, W. B., & Castelli, W. P. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91133-7 · Cited by 798
Left Ventricular Mass and Incidence of Coronary Heart Disease in an Elderly Cohort
Levy, D. A., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-2-101 · Cited by 700
Electrocardiographic Left Ventricular Hypertrophy and Risk of Coronary Heart Disease
Kannel, W. B., Gordon, T., Castelli, W. P., & MARGOLIS, J. R. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-6-813 · Cited by 638
Ventricular Arrhythmias in Patients with Hypertensive Left Ventricular Hypertrophy
McLenachan, J. M., Henderson, E., Morris, K. I., & Dargie, H. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709243171302 · Cited by 576

Show all 28 references

Research works printed but not linked: 2

Levy, 1987, Circulation, 76, IV-143
Marcus, 1987, Circulation, 75, I-19

Sorted by citations

Items 101–200 of 1,020

Histone Deacetylases 5 and 9 Govern Responsiveness of the Heart to a Subset of Stress Signals and Play Redundant Roles in Heart Development
Chang, S., McKinsey, T. A., Zhang, C. L., Richardson, J. A., Hill, J. A., & Olson, E. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8467-8476.2004 · Cited by 612
Hypoxia-Inducible Factor 1 and Cardiovascular Disease
Semenza, G. L. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170322 · Cited by 624
Reversal of Left Ventricular Hypertrophy in Essential Hypertension
Schmieder, R. E. (1996) · JAMA · doi:10.1001/jama.1996.03530430051039 · Cited by 599
Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)
Marwick, T. H., Gillebert, T. C., Aurigemma, G. P., Chirinos, J. A., Dérumeaux, G., Galderisi, M., Gottdiener, J. S., Haluska, B. A., Ofili, E., Segers, P., et al. (2015) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2015.05.002 · Cited by 587
Cardiovascular disease and chronic renal disease: A new paradigm
Sarnak, M. J., & Levey, A. S. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70239-3 · Cited by 584
Increased Pulse Pressure and Risk of Heart Failure in the Elderly
Chae, C. U. (1999) · JAMA · doi:10.1001/jama.281.7.634 · Cited by 575
Effects of the DASH Diet Alone and in Combination With Exercise and Weight Loss on Blood Pressure and Cardiovascular Biomarkers in Men and Women With High Blood Pressure
Blumenthal, J. A. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.470 · Cited by 606
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
Oliver, P. M., Fox, J. E., Kim, R., Rockman, H. A., Kim, H., Reddick, R. L., Pandey, K. N., Milgram, S., Smithies, O., & Maeda, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14730 · Cited by 570
Risk stratification in hypertension: new insights from the Framingham study*1
Kannel, W. B. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00252-6 · Cited by 578
Age-Specific Reference Intervals for Indexed Left Ventricular Mass in Children
Khoury, P. R., Mitsnefes, M. M., Daniels, S. R., & Kimball, T. R. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2009.03.003 · Cited by 570
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study
Wachtell, K., Ibsen, H., Olsen, M. H., Borch-Johnsen, K., Lindholm, L. H., Mogensen, C. E., Dahlf, B., Devereux, R. B., Beevers, G., de Faire, U., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00008 · Cited by 557
Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor Ramipril
Mathew, J., Sleight, P., Lonn, E., Johnstone, D. E., Pogue, J., Yi, Q., Bosch, J., Sussex, B. A., Probstfield, J. L., & Yusuf, S. (2001) · Circulation · doi:10.1161/hc3901.096700 · Cited by 552
Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)
Galderisi, M., Anderson, K. M., Wilson, P. W. F., & Levy, D. A. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90716-x · Cited by 551
Prognosis of left ventricular geometric patterns in the Framingham heart study
Krumholz, H. M., Larson, M. G., & Levy, D. A. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00473-4 · Cited by 537
Growth Hormone and the Heart
Saccà, L., Cittadini, A., & Fazio, S. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-5-555 · Cited by 538
Predictors of Thromboembolism in Atrial Fibrillation: II. Echocardiographic Features of Patients at Risk
The Stroke Prevention in Atrial Fibrillation Investigators (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-6 · Cited by 546
Arterial hypertension in adults. Clinical guidelines 2020
Kobalava, Z. D., Конради, А. О., Nedogoda, S. V., Shlyakhto, E. V., Arutyunov, G. P., Баранова, Е. И., Барбараш, О. Л., Бойцов, С. А., Вавилова, Т. В., Вадимовна, В. С., et al. (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-3-3786 · Cited by 609
Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade
HALL, S. A., Cigarroa, C. G., Marcoux, L., Risser, R. C., Grayburn, P. A., & Eichhorn, E. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00543-y · Cited by 534
Akt1 Is Required for Physiological Cardiac Growth
DeBosch, B. J., Treskov, I., Lupu, T. S., Weinheimer, C. J., Kovács, A. D., COURTOIS, M. R., & Muslin, A. J. (2006) · Circulation · doi:10.1161/circulationaha.105.595231 · Cited by 536
Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy
McMullen, J. R., Shioi, T., Zhang, L., Tarnavski, O., Sherwood, M. C., Kang, P. M., & Izumo, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934654100 · Cited by 534
Aortic pulse wave velocity index and mortality in end-stage renal disease
Blacher, J., Safar, M. E., Guérin, A. P., Pannier, B., Marchais, S. J., & London, G. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00932.x · Cited by 531
Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: The Cardiovascular Health Study
Aurigemma, G. P., Gottdiener, J. S., Shemanski, L. R., Gardin, J. M., & Kitzman, D. W. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01110-x · Cited by 528
Sphygmomanometrically Determined Pulse Pressure Is a Powerful Independent Predictor of Recurrent Events After Myocardial Infarction in Patients With Impaired Left Ventricular Function
Mitchell, G. F., Moyé, L. A., Braunwald, E., Rouleau, J. L., Bernstein, V., Geltman, E. M., Flaker, G. C., Pfeffer, M. A., & for the SAVE Investigators (1997) · Circulation · doi:10.1161/01.cir.96.12.4254 · Cited by 527
Continuous Relation Between Left Ventricular Mass and Cardiovascular Risk in Essential Hypertension
Schillaci, G., Verdecchia, P., Porcellati, C., Cuccurullo, O., Cosco, C., & Perticone, F. (2000) · Hypertension · doi:10.1161/01.hyp.35.2.580 · Cited by 532
Athlete’s heart
Scharhag, J., Schneider, G. K., Urhausen, A. J. P., Rochette, V., Kramann, B. H., & Kindermann, W. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02478-6 · Cited by 525
Prevalence and Prognostic Significance of Heart Failure Stages
Ammar, K. A., Jacobsen, S. J., Mahoney, D. W., Kors, J. A., Redfield, M. M., Burnett, J. C. J., & Rodeheffer, R. J. (2007) · Circulation · doi:10.1161/circulationaha.106.666818 · Cited by 530
Alterations of Cardiac Structure in Patients With Isolated Office, Ambulatory, or Home Hypertension
Sega, R., Trocino, G., Lanzarotti, A., Carugo, S., Cesana, G., Schiavina, R., Valagussa, F., Bombelli, M., Giannattasio, C., Zanchetti, A., et al. (2001) · Circulation · doi:10.1161/hc3701.096100 · Cited by 512
Inhibitory Effects of Antioxidants on Neonatal Rat Cardiac Myocyte Hypertrophy Induced by Tumor Necrosis Factor-α and Angiotensin II
Nakamura, K., Fushimi, K., Kouchi, H., Mihara, K., Miyazaki, M., Ohe, T., & Namba, M. (1998) · Circulation · doi:10.1161/01.cir.98.8.794 · Cited by 510
Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function: Sex-Related Differences in the Framingham Heart Study
Rutter, M. K., Parise, H., Benjamin, E. J., Levy, D., Larson, M. G., Meigs, J. B., Nesto, R. W., Wilson, P. W. F., & Vasan, R. S. (2003) · Circulation · doi:10.1161/01.cir.0000045671.62860.98 · Cited by 511
Heart rate and the cardiovascular risk
Palatini, P., & Julius, S. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715010-00001 · Cited by 508
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
Lonn, E., Yusuf, S., Jha, P., Montague, T. J., Teo, K. K., Benedict, C. R., & Pitt, B. (1994) · Circulation · doi:10.1161/01.cir.90.4.2056 · Cited by 497
Renal Sympathetic Denervation Reduces Left Ventricular Hypertrophy and Improves Cardiac Function in Patients With Resistant Hypertension
Brandt, M. C., Mahfoud, F., Reda, S., Schirmer, S. H., Erdmann, E., Böhm, M., & Hoppe, U. C. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.034 · Cited by 501
Calcineurin?NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs
Molkentin, J. D. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.01.021 · Cited by 504
Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort
Valente, A. M., Gauvreau, K., Assenza, G. E., Babu‐Narayan, S. V., Schreier, J., Gatzoulis, M. Α., Groenink, M., Inuzuka, R., Kilner, P. J., Koyak, Z., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-304958 · Cited by 501
Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction: The Framingham Heart Study
Vasan, R. S., Benjamin, E. J., Larson, M. G., Leip, E. P., Wang, T. J., Wilson, P. W. F., & Levy, D. (2002) · JAMA · doi:10.1001/jama.288.10.1252 · Cited by 493
Self-citation
Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention
Levin, A., Singer, J., Thompson, C. R., Ross, H., & Lewis, M. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90357-1 · Cited by 709
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy
Takemoto, M., Node, K., Nakagami, H., Liao, Y., Grimm, M. F., Takemoto, Y., Kitakaze, M., & Liao, J. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13350 · Cited by 485
Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barré, P. E. (1996) · Kidney International · doi:10.1038/ki.1996.194 · Cited by 490
Cardiovascular Morbidity in Long-Term Survivors of Metastatic Testicular Cancer
Meinardi, M. T., Gietema, J. A., Graaf, W. T. A. V. D., van Veldhuisen, D. J., Runne, M. A., Sluiter, W. J., de Vries, E. G. E., Willemse, P. H. B., Mulder, N. H., van den Berg, M. P., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1725 · Cited by 488
Myocardial fibrosis: functional significance and regulatory factors
Weber, K. T., Brilla, C. G., & Janicki, J. S. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.3.341 · Cited by 480
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
Antos, C. L., McKinsey, T. A., Frey, N., Kutschke, W. J., McAnally, J., Shelton, J. M., Richardson, J. A., Hill, J. A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231619298 · Cited by 476
GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective
Adela, R., & Banerjee, S. K. (2015) · Journal of Diabetes Research · doi:10.1155/2015/490842 · Cited by 474
Effects of Long-term Enalapril Therapy on Cardiac Structure and Function in Patients With Left Ventricular Dysfunction
Greenberg, B., Quiñones, M. A., Koilpillai, C. J., Limacher, M. C., Shindler, D. M., Benedict, C. R., & Shelton, B. J. (1995) · Circulation · doi:10.1161/01.cir.91.10.2573 · Cited by 473
Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol
Devereux, R. B., Dahlöf, B., Gerdts, E., Boman, K., Nieminen, M. S., Papademetriou, V., Rokkedal, J. E., Harris, K. E., Edelman, J. M., & Wachtell, K. (2004) · Circulation · doi:10.1161/01.cir.0000141573.44737.5a · Cited by 469
Preterm Heart in Adult Life
Lewandowski, A. J., Augustine, D. X., Lamata, P., Davis, E., Lazdam, M., Francis, J. M., McCormick, K. P., Wilkinson, A. R., Singhal, A., Lucas, A., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.126920 · Cited by 469
Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human
Haghighi, K., Kolokathis, F., Pater, L., Lynch, R. A., Asahi, M., Gramolini, A. O., Fan, G.-C., Tsiapras, D., Hahn, H. S., Adamopoulos, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17892 · Cited by 478
The Prognostic Role of Left Ventricular Hypertrophy in Patients with or without Coronary Artery Disease
Ghali, J. K., Liao, Y., Simmons, B. E., Castañer, A., Cao, G., & Cooper, R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-10-831 · Cited by 461
Sodium sensitivity and cardiovascular events in patients with essential hypertension
Morimoto, A., Uzu, T., Fujii, T., Nishimura, M., Kuroda, S., Nakamura, S., Inenaga, T., & Kimura, G. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05189-1 · Cited by 461
Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy
Schlaich, M. P., Kaye, D. M., Lambert, E., Sommerville, M., Socratous, F., & Esler, M. D. (2003) · Circulation · doi:10.1161/01.cir.0000081775.72651.b6 · Cited by 459
Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology
Tsao, C. W., & Vasan, R. S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv337 · Cited by 457
Left Ventricular Hypertrophy and Abnormal Ventricular Geometry in Children and Adolescents with Obstructive Sleep Apnea
Amin, R. S., Kimball, T. R., Bean, J. A., Jeffries, J. L., Willging, J. P., Cotton, R. T., Witt, S. A., Glascock, B. J., & Daniels, S. R. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2105118 · Cited by 452
Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia
Wilkinson, I. B., Prasad, K., Hall, I. R., Thomas, A., MacCallum, H., Webb, D. J., Frenneaux, M. P., & Cockcroft, J. R. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01723-0 · Cited by 448
Signaling effectors underlying pathologic growth and remodeling of the heart
van Berlo, J. H., Maillet, M., & Molkentin, J. D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62839 · Cited by 460
Effects of Subclinical Thyroid Dysfunction on the Heart
Biondi, B., Palmieri, E. A., Lombardi, G., & Fazio, S. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-11-200212030-00011 · Cited by 443
Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy
Mancia, G., Zanchetti, A., Agebiti-Rosei, E., Benemio, G., De Cesaris, R., Fogari, R., Pessino, A., Porcellati, C., Salvetti, A., & Trimarco, B. (1997) · Circulation · doi:10.1161/01.cir.95.6.1464 · Cited by 596
Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association
de Ferranti, S. D., Steinberger, J., Ameduri, R. K., Baker, A., Gooding, H. C., Kelly, A. S., Mietus‐Snyder, M., Mitsnefes, M. M., Peterson, A. L. H., St‐Pierre, J., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000618 · Cited by 464
The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer
Smith, J. C., Bennett, S., Evans, L. M., Kynaston, H. G., Parmar, M., Mason, M. D., Cockcroft, J. R., Scanlon, M. F., & Davies, J. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7851 · Cited by 458
Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction
Shah, A. M., Shah, S. J., Anand, I. S., Sweitzer, N. K., O’Meara, E., Heitner, J. F., Sopko, G. S., Li, G., Assmann, S. F., McKinlay, S. M., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000887 · Cited by 437
Animal Models of Heart Failure: A Scientific Statement From the American Heart Association
Houser, S. R., Margulies, K. B., Murphy, A. M., Spinale, F. G., Francis, G. S., Prabhu, S. D., Rockman, H. A., Kass, D. A., Molkentin, J. D., Sussman, M. A., et al. (2012) · Circulation Research · doi:10.1161/res.0b013e3182582523 · Cited by 435
Management of High Blood Pressure in African Americans Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks
Douglas, J. G. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.5.525 · Cited by 431
Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex
Li, H., Kedar, V., Zhang, C., McDonough, H., Arya, R., Wang, D.-Z., & Patterson, C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22220 · Cited by 439
2013 ESH/ESC Guidelines for the management of arterial hypertension
Mancia, G., Fagard, R. H., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T. C., Cífková, R., Backer, G. D., Dominiczak, A. F., et al. (2013) · Blood Pressure · doi:10.3109/08037051.2013.812549 · Cited by 430
Oxygen Free Radical Release in Human Failing Myocardium Is Associated With Increased Activity of Rac1-GTPase and Represents a Target for Statin Treatment
Maack, C., Kartes, T., Kilter, H., Schäfers, H., Nickenig, G., Böhm, M., & Laufs, U. (2003) · Circulation · doi:10.1161/01.cir.0000091084.46500.bb · Cited by 424
Left Ventricular Geometry and Severe Left Ventricular Hypertrophy in Children and Adolescents With Essential Hypertension
Daniels, S. R., Loggie, J. M. H., Khoury, P. R., & Kimball, T. R. (1998) · Circulation · doi:10.1161/01.cir.97.19.1907 · Cited by 424
BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure
Anand, P., Brown, J. D., Lin, C. Y., Qi, J., Zhang, R., Artero, P. C., Alaiti, M. A., Bullard, J., Alazem, K., Margulies, K. B., et al. (2013) · Cell · doi:10.1016/j.cell.2013.07.013 · Cited by 406
“The pathologic nature of this process has been validated in large epidemiologic studies, which demonstrate that the presence of chronic cardiac hypertrophy is a robust predictor of subsequent HF and death (Hill and Olson, 2008; Levy et al., 1990).”
Roles of Cardiac Transcription Factors in Cardiac Hypertrophy
Akazawa, H., & Komuro, I. (2003) · Circulation Research · doi:10.1161/01.res.0000072977.86706.23 · Cited by 408
Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass
Verdecchia, P., Schillaci, G., Borgioni, C., Ciucci, A., Battistelli, M., Bartoccini, C., Santucci, A., Santucci, C., Reboldi, G., & Porcellati, C. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00424-o · Cited by 408
M-Mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the cardiovascular health study)
Gardin, J. M., McClelland, R. L., Kitzman, D. W., Lima, J. A. C., Bommer, W. J., Klopfenstein, H. S., Wong, N. D., Smith, V. E., & Gottdiener, J. S. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01460-6 · Cited by 407
Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product
Molloy, T. J., Okin, P. M., Devereux, R. B., & Kligfield, P. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90376-x · Cited by 406
The Insulin-like Growth Factor 1 Receptor Induces Physiological Heart Growth via the Phosphoinositide 3-Kinase(p110α) Pathway
McMullen, J. R., Shioi, T., Huang, W., Zhang, L., Tarnavski, O., Bisping, E. H., Schinke, M., Kong, S. W., Sherwood, M. C., Brown, J. S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310405200 · Cited by 403
Ambulatory Pulse Pressure
Verdecchia, P., Schillaci, G., Borgioni, C., Ciucci, A., Pede, S., & Porcellati, C. (1998) · Hypertension · doi:10.1161/01.hyp.32.6.983 · Cited by 402
Endothelin-1 Is Involved in Mechanical Stress-induced Cardiomyocyte Hypertrophy
Yamazaki, T., Komuro, I., Kudoh, S., Zou, Y., Shiojima, I., Hiroi, Y., Mizuno, T., Maemura, K., Kurihara, H., Aikawa, R., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.3221 · Cited by 396
DIFFERENCES BETWEEN PATHOLOGICAL AND PHYSIOLOGICAL CARDIAC HYPERTROPHY: NOVEL THERAPEUTIC STRATEGIES TO TREAT HEART FAILURE
McMullen, J. R., & Jennings, G. L. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04585.x · Cited by 396
Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults.
de Simone, G., Devereux, R. B., Roman, M. J., Alderman, M. H., & Laragh, J. H. (1994) · Hypertension · doi:10.1161/01.hyp.23.5.600 · Cited by 391
Diagnosis of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons
Qaseem, A., Fihn, S. D., Williams, S., Dallas, P., Owens, D. K., & Shekelle, P. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-10-201211200-00010 · Cited by 391
Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products
Okin, P. M., Roman, M. J., Devereux, R. B., & Kligfield, P. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00371-v · Cited by 393
Remodeling of Left Ventricular Hypertrophy in Elite Athletes After Long-Term Deconditioning
Pelliccia, A., Maron, B. J., De Luca, R., Di Paolo, F. M., Spataro, A., & Culasso, F. (2002) · Circulation · doi:10.1161/hc0802.104534 · Cited by 390
Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography
Tsang, T. S. M., Barnes, M. E., Gersh, B. J., Takemoto, Y., Rosales, A. G., Bailey, K. R., & Seward, J. B. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00943-4 · Cited by 390
Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: The Strong Heart Study (SHS)
Kizer, J. R., Bella, J. N., Palmieri, V., Liu, J. E., Best, L. G., Lee, E. T., Roman, M. J., & Devereux, R. B. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.031 · Cited by 390
Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy.
Bogoyevitch, M. A., Glennon, P. E., Andersson, M., Clerk, A., Lazou, A., Marshall, C. J., Parker, P. J., & Sugden, P. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42228-9 · Cited by 388
The Effects of Obesity, Gender, and Ethnic Group on Left Ventricular Hypertrophy and Geometry in Hypertensive Children: A Collaborative Study of the International Pediatric Hypertension Association
Hanevold, C. D., Waller, J. L., Daniels, S. R., Portman, R. J., & Sorof, J. M. (2004) · PEDIATRICS · doi:10.1542/peds.113.2.328 · Cited by 383
Cardiac myocytes and fibroblasts contain functional estrogen receptors1
Grohé, C., Kahlert, S., Löbbert, K., Stimpel, M., Karas, R. H., Vetter, H., & Neyses, L. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01179-4 · Cited by 382
Potassium and Health
Weaver, C. M. (2013) · Advances in Nutrition · doi:10.3945/an.112.003533 · Cited by 405
Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study
Verdecchia, P., Carini, G., Circo, A., Dovellini, E. V., Giovannini, E., Lombardo, M., Solinas, P., Gorini, M., & Maggioni, A. P. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01663-1 · Cited by 381
Midwall Left Ventricular Mechanics: An Independent Predictor of Cardiovascular Risk in Arterial Hypertension
de Simone, G., Devereux, R. B., Koren, M. J., Mensah, G. A., Casale, P. N., & Laragh, J. H. (1996) · Circulation · doi:10.1161/01.cir.93.2.259 · Cited by 374
Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement
Fink, C., Ergün, S., Kralisch, D., Remmers, U., Weil, J., & Thomas Eschenhagen, A. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.669 · Cited by 378
Genetic Alterations That Inhibit In Vivo Pressure-Overload Hypertrophy Prevent Cardiac Dysfunction Despite Increased Wall Stress
Esposito, G., Rapacciuolo, A., Prasad, S. V. N., Takaoka, H., THOMAS, S. A., Koch, W. J., & Rockman, H. A. (2002) · Circulation · doi:10.1161/hc0102.101365 · Cited by 371
Heat Shock Proteins and Cardiovascular Pathophysiology
Snoeckx, L. H. E. H., Cornelussen, R. N., van Nieuwenhoven, F. A., Reneman, R. S., & Vusse, G. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.4.1461 · Cited by 374
Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes
Wettschureck, N., Rütten, H., Zywietz, A., Gehring, D., Wilkie, T. M., Chen, J., Chien, K. R., & Offermanns, S. (2001) · Nature Medicine · doi:10.1038/nm1101-1236 · Cited by 373
Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease
Sabit, R., Bolton, C. E., Edwards, P. H., Pettit, R. J., Evans, W. D., McEniery, C. M., Wilkinson, I. B., Cockcroft, J. R., & Shale, D. J. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-067oc · Cited by 373
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
Izumi, C., Eishi, K., Ashihara, K., Arita, T., Otsuji, Y., Kunihara, T., Komiya, T., Shibata, T., Seo, Y., Daimon, M., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0135 · Cited by 373
Association of Angiotensin-Converting Enzyme Gene I/D Polymorphism With Change in Left Ventricular Mass in Response to Physical Training
Montgomery, H. E., Clarkson, P., Dollery, C. M., Prasad, K., Losi, M.-A., Hemingway, H., Statters, D., Jubb, M., Girvain, M., Varnava, A., et al. (1997) · Circulation · doi:10.1161/01.cir.96.3.741 · Cited by 362
The Transcription Factors GATA4 and GATA6 Regulate Cardiomyocyte Hypertrophy in Vitro and in Vivo
Liang, Q., Windt, L. J. D., Witt, S. A., Kimball, T. R., Markham, B. E., & Molkentin, J. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102174200 · Cited by 363
Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment
Falcão‐Pires, I., & Leite-Moreira, A. F. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9257-z · Cited by 369
Endothelin as a regulator of cardiovascular function in health and disease
Haynes, W. G., & Webb, D. J. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816080-00001 · Cited by 360
Gender differences and normal left ventricular anatomy in an adult population free of hypertension
Salton, C. J., Chuang, M. L., O’Donnell, C. J., Kupka, M. J., Larson, M. G., Kissinger, K. V., Edelman, R. R., Levy, D. A., & Manning, W. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01712-6 · Cited by 353
2007 ESH‐ESC Guidelines for the management of arterial hypertension
Mansia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Blood Pressure · doi:10.1080/08037050701461084 · Cited by 361
Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathwayPreprint
Shiojima, I., & Walsh, K. X. (2006) · Genes & Development · doi:10.1101/gad.1492806 · Cited by 357
The FOXO3a Transcription Factor Regulates Cardiac Myocyte Size Downstream of AKT Signaling
Skurk, C., Izumiya, Y., Maatz, H., Razeghi, P., Shiojima, I., Sandri, M., Sato, K., Zeng, L., Schiekofer, S., Pimentel, D. R., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500528200 · Cited by 355
Effects of Regular Exercise on Blood Pressure and Left Ventricular Hypertrophy in African-American Men with Severe Hypertension
Kokkinos, P. F., Narayan, P., Colleran, J. A., Pittaras, A., Notargiacomo, A., Reda, D., & Papademetriou, V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332204 · Cited by 354

Authors: Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P.
Affiliations: National Heart, Lung, and Blood Institute (US)
National Center for Health Statistics (US)
Boston University (US)
ORCID: Levy, Daniel
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1990-05-31
Volume: 322
Issue: 22
Pages: 1561-1566
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199005313222203
OpenAlex: W2334499091
Cited by: 5,699
References: 28
Citations by year: 2026: 77 · 2025: 76 · 2024: 85 · 2023: 100 · 2022: 117 · 2021: 124 · 2020: 156 · 2019: 142 · 2018: 134 · 2017: 170 · 2016: 189 · 2015: 211 · 2014: 215 · 2013: 199 · 2012: 215
FWCI: 76.54
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Keywords: left ventricular mass, left ventricular hypertrophy, cardiovascular disease incidence, cardiovascular mortality, all-cause mortality, echocardiography, cardiovascular risk factors, hypertension, sex differences, Framingham Heart Study
MeSH terms: Blood Pressure, Echocardiography, Female, Follow-Up Studies, Cardiomegaly, Humans, Lipids, Male, Middle Aged, Prognosis, Risk Factors, Smoking, Multivariate Analysis, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks